Lexicon Pharmaceuticals, Inc. financial data

Symbol
LXRX on Nasdaq
Location
2445 Technology Forest Blvd., Suite 1100, The Woodlands, TX
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 399 % -57.7%
Quick Ratio 0.54 % -65.3%
Debt-to-equity 98.1 % +39.6%
Return On Equity -83.6 % +21.2%
Return On Assets -42.2 % +32.3%
Operating Margin -203 % +96.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 363M shares +0.53%
Entity Public Float 297M USD +8.55%
Common Stock, Value, Issued 366K USD +0.83%
Weighted Average Number of Shares Outstanding, Basic 363M shares +16.9%
Weighted Average Number of Shares Outstanding, Diluted 364M shares +17%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 58.4M USD +1505%
Revenue from Contract with Customer, Excluding Assessed Tax 6.17M USD +180%
Research and Development Expense 83.5M USD +29.8%
Costs and Expenses 177M USD -11.9%
Operating Income (Loss) -118M USD +39.9%
Net Income (Loss) Attributable to Parent -121M USD +40.3%
Earnings Per Share, Basic 0 USD/shares +59%
Earnings Per Share, Diluted 0 USD/shares +59%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 21.4M USD -40%
Accounts Receivable, after Allowance for Credit Loss, Current 2.18M USD -16.7%
Inventory, Net 168K USD -71.3%
Other Assets, Current 3.73M USD -51.5%
Assets, Current 145M USD -54.8%
Property, Plant and Equipment, Net 2.13M USD +9.11%
Operating Lease, Right-of-Use Asset 4.46M USD -14.1%
Goodwill 44.5M USD 0%
Other Assets, Noncurrent 368K USD -55.6%
Assets 226M USD -39.6%
Accounts Payable, Current 5.9M USD -51.7%
Employee-related Liabilities, Current 4.29M USD -53.2%
Accrued Liabilities, Current 11.5M USD -26.7%
Contract with Customer, Liability, Current 17.5M USD
Liabilities, Current 34.8M USD +25%
Long-term Debt and Lease Obligation 5.48M USD +447%
Operating Lease, Liability, Noncurrent 4.44M USD -9.23%
Other Liabilities, Noncurrent 5.2M USD -13.3%
Liabilities 96.1M USD -27.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -14K USD +92.7%
Retained Earnings (Accumulated Deficit) -1.99B USD -6.46%
Stockholders' Equity Attributable to Parent 129M USD -46.1%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 129M USD -46.1%
Liabilities and Equity 226M USD -39.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -43.8M USD +20.6%
Net Cash Provided by (Used in) Financing Activities -572K USD -100%
Net Cash Provided by (Used in) Investing Activities 40.6M USD
Common Stock, Shares Authorized 450M shares 0%
Common Stock, Shares, Issued 366M shares +0.76%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.77M USD -105%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 50.4M USD +41.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.97M USD -8.87%
Deferred Tax Assets, Valuation Allowance 421M USD +7.88%
Deferred Tax Assets, Gross 422M USD +7.79%
Operating Lease, Liability 5.34M USD -13.5%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -120M USD +40.4%
Lessee, Operating Lease, Liability, to be Paid 7.91M USD -15%
Property, Plant and Equipment, Gross 4.57M USD +20.6%
Operating Lease, Liability, Current 909K USD -29.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 865K USD -29.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 518K USD -25%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 Rate 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.56M USD -17.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 881K USD +1.85%
Deferred Tax Assets, Operating Loss Carryforwards 316M USD +9.63%
Preferred Stock, Shares Issued 2.3M shares 0%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 898K USD +1.93%
Additional Paid in Capital 2.12B USD +0.5%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 176K USD +22.2%
Share-based Payment Arrangement, Expense 10.5M USD -35.6%
Interest Expense 8.78M USD +345%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%